These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6838286)

  • 1. Hypotensive action of verapamil in a group of hydralazine-dependent hypertensive patients.
    González-Gómez A; Gamio-Capestany F; García-Barreto D
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):268-77. PubMed ID: 6838286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
    McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
    J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil in essential hypertension: a comparison with atenolol plus hydralazine.
    Horvath JS; Fletcher PJ; Bailey BP; Duggin GG; Hall B; Tiller D
    Clin Exp Hypertens A; 1987; 9(7):1185-95. PubMed ID: 3621635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.
    Lins LE; Berglund J; Eliasson K; Wernersson B
    Clin Ther; 1983; 5(3):251-9. PubMed ID: 6850719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
    Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
    Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between verapamil plasma concentrations and its antihypertensive action.
    Gonzalez-Gomez A; Cires Pujols M; Gamio Capestany F; Rodriguez de la Vega A; Garcia-Barreto D
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):453-60. PubMed ID: 3198301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil and propranolol: a comparison of two antihypertensive agents.
    Leonetti G; Pasotti C; Ferrari GP; Zanchetti A
    Acta Med Scand Suppl; 1984; 681():137-41. PubMed ID: 6587752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
    van Baak MA; Böhm RO; Petri J; Rahn KH
    Int J Sports Med; 1987 Aug; 8(4):270-4. PubMed ID: 3667024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine in the management of symptomatic sinus bradycardia.
    Weiss AT; Rod JL; Gotsman MS; Lewis BS
    Eur J Cardiol; 1981; 12(5):261-70. PubMed ID: 7250168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. A double-blind crossover study.
    Kalowski S; Hua AS; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Oct; 2(8):439-40. PubMed ID: 318493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
    Knorr A; Garthoff B
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil improves left ventricular filling and exercise performance in hypertensive and normotensive elderly individuals.
    Petrella RJ; Nichol PM; Cunningham DA; Paterson DH
    Can J Cardiol; 1994 Dec; 10(10):973-81. PubMed ID: 7994666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
    Lenz ML; Pool JL; Laddu AR; Varghese A; Johnston W; Taylor AA
    Am J Hypertens; 1995 Feb; 8(2):133-45. PubMed ID: 7755941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients].
    Actis E; Amato EA; Palmero HA; Rebora EH; Fernández Vidal JM
    Medicina (B Aires); 1978; 38(6 Pt 1):673-8. PubMed ID: 750859
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.